Replies to post #1310 on ReWalk Robotics Ltd (RWLK)

[midastouch017]

Finally going to $8.00++ ???

Not today, but RLWK is certainly on
the right tracks!

ReWalk Robotics Ltd (RWLK)
1.49 ? 0.31 (26.27%)
Volume: 2,338,219 @12/10/20 8:10:52 AM

[midastouch017]

ReWalk Robotics rallies on contract with German private health insurance company

Dec. 10, 2020 8:51 AM ETReWalk Robotics Ltd. (RWLK)By: Khyathi Dalal, SA News Editor

ReWalk Robotics (NASDAQ:RWLK) +31.6% PM, entered into a contract with a German private health insurance company for allowing all eligible beneficiaries with spinal cord injury (SCIs) to apply for the procurement of a ReWalk 6.0 exoskeleton system.

This follows a series of contracts with several statutory health insurance companies in Germany, which ReWalk signed earlier this year.

Under contract terms, eligible individuals can receive a ReWalk Personal 6.0 exoskeleton for everyday use after successful training, which can enable individuals with SCIs to stand and walk again.

Very Nice!

:-)

[mick]

thank you for updating wow [Finally going to $8.00++ ???]


Leading German Private Health Insurer Enters Contract to Provide ReWalk Exoskeletons to Individuals with Spinal Cord Injuries

7:00 am ET December 10, 2020 (Globe Newswire)

Supply contract is the Company's first with a private health insurer in Germany

ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for people with lower extremity disabilities, today announced it has entered into a contract with a German private health insurance company to allow all eligible beneficiaries with spinal cord injury (SCIs) to apply for the procurement of a ReWalk 6.0 exoskeleton system.

The contractual agreement is the first such agreement with a private health insurer and follows a series of contracts with several statutory health insurance companies in Germany, which ReWalk signed earlier this year. Under the terms of this contract, eligible individuals can receive a ReWalk Personal 6.0 exoskeleton for everyday use after successful training, which can enable individuals with SCIs to stand and walk again.

"The ready adoption of supply contracts by public and private insurers across Germany supports exoskeleton devices for spinal cord injury becoming a standard of care for qualified beneficiaries," said ReWalk CEO Larry Jasinski. "This new insurer is leading by example, and creating meaningful change in the lives of all those who will be able to procure a device and begin ReWalking in their communities."

In 2018, the ReWalk 6.0 personal exoskeleton system was listed in the Medical Device Directory (MDD) of the National Association of Statutory Health Insurance Funds in Germany, which includes all approved devices for insurance procurement. That addition was a critical turning point that enabled any of Germany's 105 statutory health insurance companies to pursue standards of care for ReWalk. After being listed in the MDD, ReWalk began to enter into supply contracts with a number of German insurers.